Medicare billing address
CMS Medicare provider billing file
2935 Maple AveZanesville, OH 43701
CMS public data · NPI 1336355973
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ross C Bloomberg, M.D.
Specialty
Credential
M.D.
NPI
1336355973
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ross C Bloomberg, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2935 Maple AveCMS Doctors & Clinicians file
2935 Maple AveIn the 2024 CMS provider billing file, this NPI had 814 Medicare beneficiaries and 4,078 total services. The average beneficiary age was 75, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$546,997.48
Total Medicare payment amount
$417,274.72
Medicare beneficiaries
814
Total services
4,078
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
39%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Chronic kidney disease
27%
CMS beneficiary-panel share
Anxiety
27%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Measurement of corneal curvature and depth of eye | 316 | $37.09 |
| Imaging of retina | 310 | $38.72 |
| Removal of cataract with insertion of prosthetic lens | 295 | $520.47 |
| Established patient complete exam of visual system | 268 | $121.24 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 268 | $88.78 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 238 | $124.83 |
| Exam of visual field with extended testing | 183 | $60.37 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 175 | $164.28 |
| Imaging of optic nerve | 162 | $34.08 |
| Injection of drug into eye | 152 | $109.22 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1336355973. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisolone Acetate | Prednisolone Acetate | 1,012 | 1,041.4 | $22,963.52 |
| 2 | Latanoprost | Latanoprost | 798 | 1,347.3 | $6,270.64 |
| 3 | Ketorolac Tromethamine | Ketorolac Tromethamine | 396 | 510.5 | $5,039.92 |
| 4 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 393 | 799.2 | $5,174.01 |
| 5 | Brimonidine Tartrate | Brimonidine Tartrate | 255 | 454.3 | $6,303.08 |
| 6 | Timolol Maleate | Timolol Maleate | 235 | 458.4 | $1,299.42 |
| 7 | Rocklatan | Netarsudil Mesylat/Latanoprost | 80 | 98 | $33,893.93 |
| 8 | Restasis | Cyclosporine | 77 | 97 | $61,377.41 |
| 9 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 71 | 71.2 | $692.62 |
| 10 | Dorzolamide Hcl | Dorzolamide Hcl | 61 | 126.6 | $1,160.37 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Ohio State University College Of Medicine
Graduation year
2004
Group/practice field
Eye Surgery Associates Of Zanesville, Inc.
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.